Collective immunity in the age of individualism: exploring the arguments of vaccination opponents

14 September 2016

By Dr Nicola Davies

Whether or not to vaccinate is one of the hottest debates in the contemporary health and pharma industry. On one hand, there is a greater amount of effective vaccines available that are able to reach a larger number of children worldwide.

On the other hand, recent data shows that mistrust towards vaccination has been slowly growing in the developed world. Such patterns could potentially sabotage collective immunization programs that are pivotal for the preservation of lives. To understand how to improve the promotion of vaccines, it is important to first understand the ideas and concerns that fuel anti-vaccine movements.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK